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ABSTRACT  Cultured bovine capillary endothelial (BCE) cells produce low levels of collagen- 
olytic activity and significant amounts of the serine protease plasminogen activator (PA). When 
grown  in  the  presence of  nanomolar quantities of  the tumor  promoter  12-O-tetradecanoyl 
phorbol-13-acetate (TPA), BCE cells produced 5-15 times more collagenolytic activity and 2-10 
times more PA than untreated cells. The enhanced production of these enzymes was dependent 
on  the dose of  TPA  used, with  maximal  response at  10  -~  to  10  -8  M.  Phorbol  didecanoate 
(PDD), an analog of TPA which is an active tumor promoter, also increased protease production. 
4-O-methyI-TPA and 4c~-PDD, two analogs of TPA which are inactive as tumor promoters, had 
no effect on protease production. Increased PA and collagenase activities were detected within 
7.5 and 19 h, respectively, after the addition of TPA. The TPA-stimulated BCE cells synthesized 
a urokinase-type PA and a typical vertebrate collagenase. 
BCE cells were compared with bovine aortic endothelial (BAE) cells and bovine embryonic 
skin (BES) fibroblasts with respect to their production of protease in response to TPA. Under 
normal growth conditions, low levels of collagenolytic activity were detected  in the culture 
fluids  from  BCE, BAE, and  BES  cells.  BCE  cells  produced  5-13  times  the  basal  levels  of 
collagenolytic activity in  response to  TPA,  whereas  BAE  cells and  BES  fibroblasts showed  a 
minimal response to TPA. Both BCE and BAE cells exhibited relatively high basal levels of PA, 
the production of which was stimulated approximately threefold by the addition of TPA. The 
observation that BCE cells and not BAE cells produced high levels of both PA and collagenase 
activities in  response to TPA  demonstrates a significant difference  between these two types 
of endothelial cells and suggests that the enhanced detectable activities are a property unique 
to bovine capillary and microvessel endothelial cells. 
Capillary proliferation in vivo is marked by fragmentation of 
the capillary basal lamina and subsequent migration and pro- 
liferation of distinct endothelial cell populations in response to 
stimuli (2). New blood vessel formation, or angiogenesis, can 
be studied in a number of systems (9,  10), and is promoted by 
angiogenic factors derived  from both normal tissues  (4,  11), 
and tumors (2, 9). Since the formation of capillaries is marked 
by both the destruction of the basal lamina and the invasion 
of cells  through  interstitial  tissue,  capillary  formation  may 
require the elaboration of proteases to degrade the proteins of 
the basal lamina  and  interstitial  stroma.  Therefore,  we have 
proposed (20)  that angiogenesis requires the secretion of pro- 
teases and have initiated experiments to characterize the pro- 
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teases  produced  by endothelial  cells  in  response  to  various 
stimuli. 
Previous work has shown that endothelial ceils derived from 
large vessels of several tissues and species synthesize at least 
two extracellular  proteases:  the  serine  protease  plasminogen 
activator (PA) and vertebrate interstitial collagenase (19). En- 
dothelial cells isolated from bovine aorta (13,  14), rabbit vena 
cava  (17),  and  human  umbilical  vein  (14)  secrete  variable 
amounts  of PA,  an  enzyme which  converts plasminogen  to 
plasmin,  a  neutral  protease  with  broad  substrate  specificity. 
The amount of PA activity is dependent upon the species and 
source of endothelium (14), the level of cellular inhibitors (17), 
and on the exact culture conditions (15). However, significantly 
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thelial  cells  by  the  inclusion  of the  tumor  promoter  12-0- 
tetradecanoyl  phorbol-13-acetate  (TPA)  in the growth media 
(14).  In contrast, the basal level of collagenase production by 
endothelial cells is quite low (19). However, in the presence of 
TPA,  human umbilical vein endothelial  cells produce signif- 
icant amounts of a latent collagenase, which, upon activation, 
is  capable  of degrading  types  I,  II,  and  III  collagens  (19). 
Bovine vein endothelial ceils also have been reported to secrete 
low levels  of a  type IV collagenase  (16).  However, no single 
endothelial cell type has been shown to synthesize significantly 
increased amounts of both collagenase and PA in response to 
TPA stimulation. 
The  endothelial  cells  involved  in  neovascularization  and 
therefore of greatest interest in terms of their protease produc- 
tion are the capillary endothelial ceils. Thus, we examined the 
synthesis of PA and collagenase  by cultured bovine capillary 
endothelial  (BCE) ceils.  To determine  if collagenase  and PA 
synthesis could be stimulated in BCE cells, we also investigated 
the modulation of these  two enzymes in response  to TPA,  a 
known  inducer  of  PA  in  endothelial  cells  (17).  Since  the 
responses  of endothelial  cells  derived  from large  vessels  and 
capillaries  may be quite different,  the levels of PA and colla- 
genase  activities  produced  by  both  BCE  and  bovine  aortic 
endothelial (BAE) cells were compared. 
MATERIALS  AND  METHODS 
Cell Culture 
BCE were isolated from bovine adrenal glands from freshly slaughtered calves 
and cloned as described by Folkman et al. (8). Growth medium consisted of an 
equal mixture of modified Eagle's medium (a-MEM with ribonucleosides; Gibeo 
Laboratories,  Grand  Island  Biological Co.,  Grand  Island,  NY)  and  tumor- 
conditioned medium (see below) supplemented with  10% (vol/vol) donor calf 
serum (Flow  Laboratories, Inc.,  RockviUe, MD)  and  1% (vol/vol)  antibiotic- 
antimycotic (Gibco Laboratories). Only those clones which uniformly produced 
Factor VIII-related antigen were maintained in liquid nitrogen for later use. 
Large vessel  endothelial cells  were  obtained  from the  aortae of the  same 
animals used above. BAE ceils were prepared as described previously (22). The 
cells were grown in  Dulbecco's modified Eagle's medium (low glucose DME, 
Gibeo Laboratories) containing 10% (vol/vol) donor calf serum unless otherwise 
stated. 
Fibroblasts were obtained from bovine embryonic skin (BES fibroblasts) using 
the same procedure as described for the preparation of chick fibroblasts (5). The 
cells were grown in DME medium with 10% (vol/vol) donor calf serum, unless 
otherwise stated. 
Dr.  J.  Folkman  (Childrens  Hospital Medical  Center,  Boston,  MA)  kindly 
supplied mouse sarcoma 180 ceils. These cells were grown in DME with  10% 
donor calf serum. The spent medium from confluent cultures was used as the 
source of tumor-conditioned medium as described by Folkman et al. (8). Cells 
used in all experiments were between fifth and tenth passage. 
Immunofluorescence for Factor VIII- 
related Antigen 
Cells were plated on 12-mm gelatin-coated sterile cover slips in 35-mm culture 
dishes. At confluence, the cover slips were removed and fixed in 100% methanol 
"(5 min, -20°C), washed in PBS, and incubated for 40 min at 37°C with a  1:100 
dilution of rabbit antiserum to bovine Factor VIII (provided by Dr. E. Davie, 
University of Washington). The cover slips were washed with PBS (three times 
for 15 rain each) and incubated for an additional 40 min at 37°C with rhodamine 
conjugated anti-rabbit IgG (1:120 dilution in PBS; N. L. Cappel Laboratories, 
Cochranvilte,  N J).  After  further  washing, the  cover  slips  were  mounted  on 
microscope slides and examined by fluorescence microscopy  at x  312 with a Leitz 
Orthomat microscope. 
Preparation of Cells for Experiments 
Cells  were  seeded  on  35-mm  gelatin-coated dishes  (1.5%  gelatin  [Sigma 
Chemical Co., St. Louis, MO] in calcium and magnesium-free PBS) and grown 
to confluence in  their respective growth media unless otherwise indicated. At 
confluence, the cells were washed twice with PBS and incubated for 18 h in DME 
with 10% (vol/vol) acid-treated (17) calf serum depleted of plasminogen (7). The 
cells were then washed twice with PBS and cultured for an additional 24 h  in 
DME  containing 5% (vol/vol)  calf serum (depleted  of plasminogen) and the 
agent to be tested. This protocol was found to effectively reduce the basal PA 
levels of BCE ceils. The postculture medium was collected, centrifuged at 400 g 
for  l0 rain to remove cells and cellular debris, and stored at -20°C. The cell 
monolayers from duplicate cultures were washed three  times  with cold PBS, 
scraped into PBS, and pelleted by centrifugation at 400 g  for 10 min. The cell 
pellets were solubilized in 250 #1 of 0.1 M Tris-HCl, pH 8.1, 0.5% Triton X-100 
and frozen at  -20°C  until total cell protein and PA assays were performed. 
Protein determinations were performed by the method of Lowry et aL (18) using 
BSA as a standard. 
Plasminogen Activator Assay 
Aliquots of Triton X-100-extracted cells (usually 0.5-1.0/tg cell protein) were 
added to 500/tl of 0.1  M Tris-HC1, pH 8.1, containing 125 ,ttg BSA and 4/tg of 
calf plasminogen (5). This mixture was added to dishes coated with ~251-fibrin 
and incubated at 37°C for 1-2 h (5). Aliquots (100 #1) were removed and counted 
in  a  Packard 5210 gamma scintillation counter. The amount of radioactivity 
released by BCE plasminogen activator was related to the amount released by 
0.001  Plough  units  of human  urokinase  standard  run  with  all  assays  (Leo 
Pharmaceutical Products, Ballerup, Denmark). The reaction was stopped when 
<20%  of the  total  radioactivity was  released  from  the  plates.  Plasminogen 
activator assays of serum-free conditioned medium were performed as described 
above except that aliquots of medium were used rather than cell lysates. 
Molecular Weight Determinations of PA 
SDS PAGE was performed as described by Crowe et al. (5). Samples were 
mixed with an equal volume of nonreducing sample buffer and loaded on an 
SDS 9% polyacrylamide  slab gel with a 3% polyacrylamide stacking gel. Electro- 
phoresis was performed at 10 mA. After electrophoresis was completed, the gel 
lanes were sliced into l-mm sections. The slices were incubated for 18 h  in 250 
#1 of 0.25% Triton X-100 in water. An equal volume of 0.2 M Tris-HC1, pH 8.1, 
with 250/~g BSA and 8 ,ag of calf plasminogen was added to each tube. The 
contents of each tube were assayed for PA activity as above. 
Molecular weight standards consisted of iodinated BSA, aldolase, and chy- 
motrypsinogen and were applied to tandem lanes in the same gel under reducing 
conditions. The gel was cut into  l-mm slices and each slice was counted for 
radioactivity in the gamma counter. 
Concanavalin A-Sepharose Chromatography 
A column (1 ml) of concanavatin A (Con A)-Sepharose was equilibrated with 
1 M NaCI containing 3.4 mM phosphate, pH 7.5, and 0.01% (vol/vol) Tween-80. 
Sample elution was carried out  with 0.6  M  a-methylmannoside in the same 
buffer. Fractions of 600 #1 were collected and 25-#1 aliquots were assayed for PA 
activity. All column procedures were performed in the cold. Serum-free condi- 
tioned  media  from confluent  BCE  control and TPA-treated (2.3  ×  10  -7  M) 
cultures were  the  sources of bovine  PA.  Cells  were grown to  confluence  in 
complete tumor-conditioned medium, incubated for 18 h in medium containing 
10% acid-treated calf serum (without plasminogen), and maintained for 23 h  in 
DME containing 10% tryptose phosphate broth with or without TPA. The latter 
conditioned medium was collected, centrifuged at 400 g, and frozen at -70°C 
until use. Tissue-type PA partially purified from serum-free conditioned medium 
from Bowes human melanoma ceils was kindly provided by D. Well (New York 
University Medical Center). Human urokinase was obtained from Leo Pharma- 
ceutical Products. All samples were dissolved in or dialyzed into the equilibrating 
buffer and were applied to the column in a total volume of 5 mL The PA activity 
of the applied samples ranged from 5 to 25 Plough units. 
Collagenase Assay 
Postculture media were thawed and activated as described by MoscateUi et 
al. (19). Latent colhgenase was activated by treating aliquots of medium (100 
~1) with trypsin (0.5 mg/ml) for 30 min. The trypsin was inactivated by adding 
soybean trypsin inhibitor to a final concentration of 5 mg/ml. For each sample 
containing >5% serum, the concentration of trypsin necessary to achieve complete 
activation  of collagenase was  determined.  The  collagenase in  the  activated 
conditioned media was assayed for its ability to cleave t2'~l-collagen-Sepharose, 
according to  the  method of Moscatelli et  al. (19).  One unit of collagenolytic 
activity is defined as the  amount of collagenase required to degrade  1 ~g of 
collagen in 1 h at 25°C. 
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The following were obtained from Consolidated Midlands (Brewster,  NY): 
12-O-tetradecanoyl  phorbol- 13-acetate, phorbol- 12,13-didecanoate,  4-O-methyl- 
12-O-tetradecanoyl  phorbol-13-acetate,  and  4-a-phorbol-12,13-didecanoate. 
Stock solutions of I and 0.1 mg/ml in ethanol were stored at -20°C. The purity 
of the TPA and TPA analog stock solutions were verified  by thin-layer chroma- 
tography. Only a single spot was observed for each corresponding to the published 
mobilities  relative  to the front (gf) values. N-ethylmaleimide, disodium ethylene- 
diaminetetraacetate,  mersalyl, Con A-Sepharose, Tween-80,  c~-methylmannoside, 
and gelatin  were obtained from Sigma Chemical Co. Soybean trypsin inhibitor 
was purchased from Miles  Laboratories (Elkhart, IN). Dr. W. Troll (New York 
University Medical  Center) kindly provided pepstatin and antipain, which were 
originally supplied by the U.S.-Japan Cooperative Cancer Research Program. 
Trasylol  a (6,600 kallikrein  inhibitory units/mg) was a gift from Farbenfabrikin 
Bayer AG (Elberfeld,  Germany). Trypsin-TPCK was from Worthington Bin- 
chemical  Corp. (Freehold, N J). 
RESULTS 
Cloned adrenal BCE cells, isolated by the procedure of Folk- 
man  et  al.  (8),  were judged to  be  microvascular endothelial 
ceils by  the  following criteria.  First, the  cells had  a  typical 
nonoverlapping cuboidal morphology and contained large nu- 
clei with prominent nucleoli (Fig.  I A). Bovine capillary and 
aortic  endothelial ceils  approaching  confluence  had  similar 
cuboidal morphologies, as shown in Fig.  1  A  and  C.  Second, 
all of the BCE cells produced Factor VIII-related antigen, as 
determined by indirect immunofluorescence. Third, BCE cells 
required tumor-conditioned medium  for optimal growth  (8). 
All experiments were performed only with cells derived from 
clones which displayed all three of these properties and thus 
were considered to be authentic capillary endothelial cells. 
Protease Production by BCE Cells 
Confluent cultures of BCE  cells maintained under  normal 
culture conditions exhibited levels of cell-associated  PA activity 
comparable  to  and  usually greater  than  the  PA  activity of 
aortic endothelial cells (13,  14) (Table I). The basal amounts 
of PA  found  in  BCE  and  BAE  cells  were  relatively high 
compared to  other  nontransformed  cell types,  such  as  BES 
fibroblasts. Like BAE cells (15), the cell-associated PA activity 
of BCE cells in vitro was found to vary with growth conditions, 
such as cell density, the species and concentration of serum in 
the culture medium, and the specific clone of BCE cells. Under 
these  same  growth  conditions,  low  levels  of collagenolytic 
activity were  detected  in  the  medium  conditioned by  BCE, 
BAE, and BES cells. 
TPA-induced Changes in BCE Cells 
Since TPA has been shown to increase PA synthesis (14) in 
some large vessel endothelial cells, and collagenase in others 
(19),  the  ability of TPA  to  modulate production  of both  of 
these enzymes in BCE cells was investigated. Within 3 h  after 
the addition of 10 -7 M  TPA to cultures of BCE,  there was a 
dramatic change in cell shape (Fig.  I A and B). The flattened 
cobblestonelike  cells  became  more  refractile  and  displayed 
numerous cell processes. The cells maintained this appearance 
as  long  as  TPA  was  present  in  the  culture  fluid.  Similar 
morphological changes were  observed when  BAE cells were 
treated with TPA (Fig. 1 C and D). 
To  determine the  amount  of TPA  required to  maximally 
induce protease secretion by BCE cells, confluent cultures were 
FIGURE  I  The morphology of unstimulated and TPA-stimulated  bovine endothelial cells. Bovine capillary and aortic endothelial 
cells were grown to confluence in their respective media and incubated with or without 2 x  I0  -TM TPA.  Photographs of untreated 
and TPA-treated cultures were taken using a phase-contrast microscope, at x  125, 2.5  h  after the addition of TPA.  (A)  BCE cell 
control.  (B)  BCE cell with  TPA.  (C)  8AIF cell control.  (D)  BAE cell with TPA. 
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Effect of TPA on PA and Collagenase Production by BCE, BAE, 
and BES Cells 
Collagenase 
PA activity  activity 
-TPA  +TPA  -TPA  +TPA 
Bovine capillary endothelium 
Bovine aortic endothelium 
Bovine embryonic skin 
mU/l.zg protein  mU/culture 
7.2  31.0  21.4  72.4 
4.7  8.8  10.9  13.5 
0.0  0.0  11.5  13.6 
Confluent cultures of BCE, BAE, and BES cells were prepared for experimental 
use as described in Materials and Methods. Duplicate cultures were incubated 
for 23 h with or without 2 x  10  -7 M TPA The culture fluids were collected, 
activated  with  trypsin,  and assayed for collagenase activity.  The cell  layers 
from the same cultures were extracted with Triton X-100  and the extracts were 
assayed  for PA. The data represent the average ot duplicate measurements. 
there was no difference between TPA-treated and untreated 
BCE ceils in the  incorporation of 3~S-methionine. Thus, the 
increased production of proteases cannot be attributed to an 
overall increase in the rate of protein synthesis. 
To investigate the effects  of TPA analogs on PA and colla- 
genase production by BCE cells, BCE cells were incubated for 
24 h with three analogs. The active tumor promoter phorbol- 
12,13-didecanoate (PDD)  stimulated cell-associated PA  and 
collagenase activities to the  same extent as TPA (Table II). 
Two analogs of TPA which are inactive as tumor promoters, 4- 
O-methyl-12-O-tetradecanoyl  phorbol-13-acetate (4-O-methyl 
TPA) and 4-a-phorbol-12,13-didecanoate  (4-a-PDD), had little 
or no effect on these activities at 2 x  10  -7 M (Table II). Thus, 
the  specific induction of PA and collagenase by analogs of 
TPA correlated with their tumor promoting potential. 
incubated for 23 h  with various concentrations of TPA. The 
PA  levels  in the  cell  layer and  in the  medium of cultures 
incubated with different TPA concentrations  are shown in Fig. 
2. After the 23-h incubation, most of the PA produced by BCE 
cells was found in the medium. However, there was an excellent 
correspondence between the stimulating effects of TPA on the 
amount of cell-associated PA  and on secreted  PA  with  the 
maximum increase in both cases occurring at 2 x  10  -a M TPA. 
With  10  -a  M  TPA  there  was  a  slight  stimulation of cell- 
associated  PA which was not reflected in secreted  PA.  This 
apparent difference may be the result of PA inactivation  in the 
medium at low concentrations of PA. In general, the changes 
in cell-associated PA reflected changes in total PA and could 
be used conveniently to  monitor changes in PA production. 
Moreover,  as  has  been  found  with  other  cells,  all  of  the 
collagenase produced by BCE ceils was secreted into the culture 
medium; no activity was found associated with the cell layer. 
Thus, PA and collagenase could be assayed in the same culture 
since PA could be measured in the cell layer and collagenase 
in the culture fluid. 
When the PA activity of the cell layer and the total colla- 
genolytic activity secreted into the culture medium were meas- 
ured, a slight enhancement of both PA and collagenase activ- 
ities occurred in the presence of 2  x  10  -9 M  TPA; maximal 
stimulation of both enzyme activities was obtained with 2  × 
10  -s  M  TPA  (Fig.  3).  The  degree  of  stimulation of these 
enzymes was variable from clone to clone but was always at 
least two- to tenfold above the basal levels of untreated cultures. 
The reason for this variation is unknown  and is presently being 
investigated. The dose response, with respect to both PA and 
collagenase production, of BCE ceils to TPA was similar to 
that observed previously for other cells (17,  19, 24). 
To  investigate whether  the  increased protease  production 
was  the  result  of an  overall increase  in  RNA  and  protein 
synthesis, the rates of RNA and protein synthesis in unstimu- 
lated  and TPA-stimulated BCE  cells were  compared.  RNA 
and protein synthesis rates were estimated from the rates of 
incorporation of 3H-uridine and 3'SS-methionine  into acid-in- 
soluble material. Untreated BCE cells and BCE cells that had 
been exposed to TPA for 20 h were given a 2-h pulse of 3H- 
uridine or a 5-h pulse of 3'~S-methionine. The amount of 3H- 
uridine or 3~S-methionine  incorporated into acid-insoluble  ma- 
terial was  determined by standard procedures  (5).  In TPA- 
treated  cultures,  25%  less  3H-uridine was  incorporated into 
acid-insoluble material than in untreated cultures. However, 
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FIGURE  2  Induction  of  cell-associated  and  secreted  PA  by  TPA. 
BCE cells were grown to confluence and prepared for experimental 
use  as  described  in  Materials  and  Methods.  The  cultures  were 
incubated  for 24  h  in  serum-free DME  containing  the  indicated 
concentrations of TPA.  The culture fluids  from  duplicate cultures 
were collected and assayed for secreted PA. The cells from the same 
cultures were extracted with  0.1  M  Tris,  pH  8.1, 0.5%  Triton  X-100 
and the extracts assayed for cell-associated PA. 
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FIGURE  3  TPA-induced  PA  and  collagenase  production  by  BCE 
cells.  BCF cells (passage 8)  were grown to confluence in complete 
tumor-conditioned medium  and prepared for experimental use,  as 
described in  Materials and Methods. The cultures were incubated 
for 23 h in DME with 5% calf serum (depleted of plasminogen) and 
various concentrations of TPA.  The culture  fluids  from  duplicate 
cultures  were  collected,  activated  with  trypsin,  and  assayed  for 
collagenase. The cells from the same cultures were extracted with 
Triton X-100 and the extracts were assayed for PA. 
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The time course of the TPA-induced stimulation of PA and 
collagenase production  by  BCE  cells was  determined.  Con- 
fluent BCE cultures were incubated with fresh media with or 
without  2  ×  10  -7  M  TPA,  and  at  regular intervals the cell- 
associated PA and secreted collagenase levels were measured. 
The PA activity of unstimulated BCE cells increased slightly 
over the 25-h period (Fig. 4): the magnitude of this increase 
was variable from experiment to experiment. However, when 
BCE cells were exposed to TPA, a  significant increase in PA 
activity above the values obtained with unstimulated BCE cells 
was detected by 7.5 h. 
Unstimulated BCE ceils secreted low levels of coUagenase 
(Fig. 4). However, within 19 h after the addition of the tumor 
promoter, increased amounts of coUagenase activity were de- 
tected in the culture fluids of TPA-treated cells (Fig. 4). The 
collagenase continued to accumulate in the medium of TPA- 
treated cultures for up to 48 h. A second dose of TPA did not 
further enhance  the rate of collagenase secretion, suggesting 
that the ceils were synthesizing collagenase at a maximum rate. 
TABLE  II 
Effect of TPA Analogs on BCE Cell PA and Collagenase 
Production 
Collagenase 
PA activity  activity 
mU/p,g protein  mU/culture 
Control (untreated)  6.6  10.5 
TPA  21.7  136.0 
PDD  24.1  131.0 
4-O-methyl TPA  6.7  16.5 
4-a-PDD  5.8  15.8 
Confluent BCE cell cultures on 35-mm dishes were exposed for 23 h to I-PA 
or its analogs at a concentration  of ~2 x  10  -7 M. The culture fluids from 
duplicate  cultures  were collected,  activated  with  trypsin,  and  assayed for 
collagenase activity.  The cell  layers from the same cultures  were extracted 
with detergent and the extracts were assayed  for PA. The data represent the 
average of duplicate  measurements. 
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FIGURE  4  Time course of TPA stimulation  of PA  and collagenase 
production  by  BCE  cells.  BCE  cells  (passage 8)  were  grown  to 
confluence in complete tumor-conditioned medium  and prepared 
for experimental use, as described in  Materials and Methods. Du- 
plicate cultures  in  35-ram  culture  dishes were  incubated  with  or 
without 2 x  10  -7 M TPA in DME containing 5% calf serum depleted 
of plasminogen. At 7.5, 19, and 25 h after the addition of TPA culture 
fluids were collected, activated with  trypsin, and assayed for colla- 
genase. The cells from the same cultures were extracted in Triton X- 
100  and  the extracts were assayed for PA.  Broken  lines  represent 
untreated cultures; continuous lines represent TPA-treated cultures. 
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FIGURE  5  PAGE of PA from BCEand MDBKcells.  BCEand MDBK 
cells were grown in their respective media for 24 h with or without 
2 x  10 -7 M  TPA.  The cells were washed, collected, and solubilized 
in  Triton  X-100.  Aliquots of the cell  extracts (20-60 mU  PA)  were 
applied to SDS 9% polyacrylamide slab gels and run under nonre- 
ducing conditions. The gel lanes were sliced (1  mm)  and each slice 
was  assayed  for  PA  activity,  as  described.  Iodinated  molecular 
weight  standards were  applied  to  the  same  gel,  under  reducing 
conditions. (A)  BCE cell control. (B)  BCE cell with TPA;  (C) MDBK 
cell control. (D)  MDBK cell with TPA. 
The ability to detect increased PA production before detecting 
an increase in collagenase production (Fig. 4) may reflect the 
greater sensitivity of the PA assay compared to the collagenase 
assay (19, 20, 23). 
Characterization  of BCE Cell PA 
and Collagenase 
Two classes of immunologically noncross-reactive PA have 
been  described, the  tissue-type and  the  urokinase-type (21). 
The tissue-type PA has a  greater molecular weight than the 
urokinase-type PA, is a  glycoprotein, and binds to fibrin (3, 
21). Urokinase differs from tissue-type PA in its sugar content 
and  does not  bind to  fibrin.  Since tissue-type PA has  been 
isolated from the plasma of cadavers and has been presumed 
to be a  product of endothelial cells, the type of PA made by 
untreated and TPA-stimulated BCE cells was investigated. 
The PA synthesized by both unstimulated and TPA-stimu- 
lated BCE cells appears to be predominantly the urokinase- 
type  based  on  the  following data.  The  apparent  molecular 
weight of the cell-associated PA from untreated (Fig. 5 A ) and 
TPA-stimulated (Fig. 5 B) BCE cells, as judged by SDS PAGE, 
was 42,500 +  1,500 daltons. This is in close agreement with the 
estimated molecular weight of the urokinase-type PA produced 
by BAE cells in vitro (15, 26). Moreover, the molecular weight 2~- 
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FIGURE  6  Con A-Sepharose chromatography of PAs. Samples with 
PA activity (5-25 U) were applied to a column of Con A-Sepharose. 
The arrow indicates the start of a-methylmannoside elutions. Frac- 
tions were assayed for PA as described in the text. (A) control BCE 
conditioned  medium,  (B)  TPA-treated  BCE conditioned  medium, 
(C)  partially purified conditioned medium from human melanoma 
ceils, and (D)  human urokinase. 
of the BCE PA was identical to the molecular weight of  the PA 
produced  by untreated  (Fig.  5 C)  and  TPA-stimulated  (Fig. 
5D)  Madin-Darby  bovine  kidney  (MDBK)  cells.  This  is 
suggestive evidence that the BCE cell PA is the urokinase-type, 
since other species of kidney cells have been shown to synthe- 
size  the  urokinase-type  PA  in  vitro  (1).  Furthermore,  like 
human urokinase, the BCE cell PA is not retained by Con A- 
Sepharose,  while  human  tissue  activator  binds  to  this  resin 
(Fig.  6).  While  not conclusive,  the present  data suggest that 
under  these  in  vitro  culture  conditions  BCE  cells  elaborate 
predominately a  urokinase-type PA. Experiments  are now in 
progress to further substantiate that the major BCE cell PA is 
urokinase-type. 
The collagenase synthesized by TPA-stimulated  BCE cells 
was also characterized.  All of the collagenase was secreted in 
a  latent form and could be activated with trypsin or with the 
sulfhydryl reagent mersalyl (19).  At 25°C, the activated BCE 
collagenase cleaved iodinated type I guinea pig skin collagen 
at  a  single  site,  resulting  in the  characteristic  TC^  and  TCa 
fragments which are three-quarters  and one-quarters,  respec- 
tively, of the length of the intact molecule (Fig. 7). Table III 
lists the effects of protease inhibitors on the activity of the BCE 
cell  collagenase.  The  collagenase  appeared  to  be  a  metallo- 
protease, as it was inhibited by EDTA but was unaffected by 
inhibitors  of serine  proteases  (antipain,  DFP,  TrasylolR),  as- 
partate  proteases  (pepstatin),  or thiol proteases  (N-ethylmal- 
FIGURE  7  Digestion of collagen by BCE cell collagenase. BCE cells 
were incubated with 10  -7 M TPA for 24 h. The medium was removed 
from  the cultures  and  activated with  trypsin  and  the trypsin  was 
inhibited with a tenfold excess of Trasylol  a. Aliquots of the medium 
containing 12  mUnits  of collagenase activity were mixed with  3 x 
10  -~/~Ci12Sl-guinea  pig skin collagen (0.35 #Ci/#g) and incubated at 
25°C for various periods of  time. The samples were then  reduced 
and boiled, loaded on an SDS 5-16%  polyacrylamide gradient gel, 
and electrophoresed. The dried gel was exposed to Kodak X-O-mat 
film for 72 hr at -70°C. Lanes: 1, control; 2-4, samples incubated at 
25°C for 2.5, 5, and 12 h, respectively. 
TaBLe III 
Effect of Protease Inhibitors on BCE Cell Collagenase Activity 
Activity 
Additions  remaining 
% 
None  100 
EDTA  (10 raM)  0 
Bovine calf serum 
(1% vol/vol)  5.9 
(2% vol/vol)  0 
Antipain (100 #g/ml)  105 
DFP (3.75 mM, added twice)  87.0 
Trasylol  R (100 #g/ml)  99.4 
Pepstatin (100 #g/ml)  90.7 
N-Ethylmaleimide (10 mM)  93.6 
Activated post-culture medium (0.1 ml) containing 5.5 mU of BCE collagenase 
activity was mixed with 0.4 ml of 0.1 M HEPES,  pH 7.6, 5 mM CaCl2, 0.5 rng/ 
ml BSA,  and the indicated concentrations of protease  inhibitors. Collagenase 
activity was measured after incubating the samples at room temperature for 
30 min. 
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inhibitors present in calf serum (Table III). Thus, the collagen- 
ase secreted by TPA-treated BCE cells had properties similar 
to those of collagenases obtained from other tissues (12) and 
from human umbilical vein endothelial cells (19). 
ever, the coordinate increase in both collagenase and inhibitor 
cannot  be  excluded.  However,  the  ability of BCE  cells  to 
increase the production of collagenolytic activity in response 
to tumor promoters is a  major difference between endothelial 
cells derived from bovine adrenal capillaries and bovine aortae. 
Protease Activities in Other Cells 
The ability of TPA to induce PA and collagenase activities 
in  BCE  cells  was  compared  to  its  ability to  induce  these 
enzymes in BAE cells and BES fibroblasts. BCE and BAE cells 
and BES fibroblasts were grown under identical conditons and 
incubated in the presence or absence of 2 ×  10  -7 M TPA for 23 
h.  The cell-associated PA levels of both untreated and TPA- 
treated cultures are shown in Table I. As mentioned previously, 
BCE  ceils and  BAE ceils from  untreated cultures exhibited 
relatively high  basal levels of PA  compared  to  PA in  BES 
fibroblasts. The  addition of TPA to  the culture medium  re- 
sulted in a two- to fourfold stimulation over basal levels of PA 
in  BCE  and  BAE  cells  but  had  no  effect  on  PA  in  BES 
fibroblasts. Although BAE cells have been reported to produce 
high levels of PA, BCE cell levels were even higher, both in 
the presence and  absence of TPA (Table I). BES  fibroblasts 
produced little or no PA under either condition. 
The amount of collagenolytic activity released into the cul- 
ture fluids by each of these cell types are shown  in Table I. 
BCE cells were the only cells to produce significantly increased 
amounts  of  activity  in  the  presence  of  TPA  compared  to 
untreated cultures. It is possible that the low levels of collagen- 
olytic activity associated with BAE ceils may be related to the 
production of a collagenase inhibitor. BAE cells were found to 
secrete  an  inhibitor of collagenase,  but  we  were  unable  to 
detect an increase in the secretion of this collagenase inhibitor 
when cells were treated with TPA (Fig. 8).  BCE cells did not 
produce an inhibitor of collagenase when assayed under these 
same conditions. The inhibitor produced by the BAE cells is 
different than  that  associated with the latent collagenase, as 
trypsin treatment  of the  culture fluid did not  inactivat~ the 
inhibitor. The lack of a significant increase in inhibitor levels 
after exposure of the ceils to TPA would argue that the lack of 
effect of TPA on  BAE cell collagenolytic activity is not the 
result of an excess production of coUagenase inhibitor. How- 
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FIGURE  8  Inhibition  of 
BCE  collagenase  by  BAE 
postculture  medium.  BAE 
cells were grown to conflu- 
ence and  prepared for ex- 
perimental  use  as  de- 
scribed  in  Materials  and 
Methods.  Four  plates  of 
BAE  cells  were  incubated 
for  24  h  in  DME  without 
serum.  The  medium  on 
two of the plates also con- 
tained  10 -7  M  TPA.  The  culture  fluids  were  collected,  dialyzed, 
concentrated tenfold, and assayed for collagenase inhibitory activity. 
The concentrated  postculture  medium  was mixed with  4.6 mU  of 
trypsin-activated BCE collagenase in 0.4 ml 0.1  M  HEPES, pH 7.6, 5 
mM CaCI2, 0.5 mg/ml  BSA and incubated at room temperature for 
30  rain.  The  collagenase  activity  remaining  in  the  sample  was 
determined. The continuous line represents the residual collagenase 
activity  in  samples containing  concentrated  postculture  medium 
from  untreated  BAE cells. The  broken  line represents the residual 
collagenase activity in samples containing concentrated postculture 
medium from TPA-treated BAE cells. 
DISCUSSION 
In this paper we have characterized the modulation by TPA of 
collagenase and  PA production by BCE cells. TPA causes a 
two  to tenfold increase in the  amount  of enzymatic activity 
produced by BCE cells. The PA produced appears to be of the 
urokinase-type as determined by its molecular weight and its 
inability to bind to Con A-Sepharose. The rather high basal 
levels of PA production by BCE cells was surprising but are 
consistent with the previous reports of high basal levels of PA 
synthesized  by  aortic  endothelial ceils  from  several animal 
species (13, 14). The coUagenase produced is found exclusively 
in  a  latent  form.  This  is  in  agreement  with  what  has  been 
observed with other types of endothelial cells (20) and appears 
to be a property of most collagenases produced in vitro (12). 
We have not yet been able to detect either a type IV or type V 
collagenase activity in TPA-stimulated BCE cell culture fluids 
(Moscatelli, D., unpublished observations). This may be due to 
the fact that these two enzymes are normally produced in very 
low  amounts  and/or  are  membrane  bound.  More  sensitive 
methods  of detection may indicate that  TPA  stimulates the 
synthesis of types IV and V  collagenase as well. Experiments 
to test this are currently in progress. 
The TPA-induced stimulation of collagenase and PA activ- 
ities was rapid and was also seen with PDD, an active analog 
of TPA. In contrast, nontumor promoting derivatives such as 
4-O-methyl  TPA  and  4  a-PDD  did  not  stimulate  enzyme 
production. 
The inability of TPA to stimulate collagenolytic activities in 
cultures of BAE cells is extremely interesting, for  this  may 
indicate an important physiological difference between  BCE 
and  BAE ceils in vitro. The  precise nature of the difference 
between BCE and BAE cells with respect to collagenase pro- 
duction  is  unknown.  We  found  that  BAE  cells  secrete  an 
inhibitor of BCE collagenase. TPA might simulate the coordi- 
nate production of both collagenase and collagenase inhibitor 
resulting in  no  significant increase in  coUagenolytic activity 
even though there was an increase in enzyme production. At 
the present time our techniques do not permit us to differentiate 
between increased production of enzyme and  increased pro- 
duction of activity. However, regardless of the mechanism for 
the lack of response of BAE cells in respect to coUagenolytic 
activity, the  differences between  the  responses of BAE and 
BCE cells to TPA differentiate the two cell types. 
The  responses  of BCE  cells is  also  significantly different 
from the human umbilical cord endothelial ceils studied pre- 
viously (19).  These human cells responded to TPA by increas- 
ing the production of collagenolytic activity with no increase 
in PA production. Therefore, only BCE cells demonstrate an 
increase of both collagenolytic and PA activities after exposure 
to TPA. 
Several differences between the growth requirements of cap- 
illary and large vessel endothelial cells have been described. 
Folkman et al. (8) demonstrated that BCE ceils required tumor- 
conditioned medium  for  survival and  proliferation, whereas 
BAE cells grew at equal rates in regular or tumor-conditioned 
medium. Davison and Karasek (6) found a growth-promoting 
980  THE Iournau  Or  CeLL BIOLOGY  •  VOLUme 95, 1982 effect ofdibutyryl cAMP on human dermal foreskin microvas- 
cular endothelial cells in vitro, in marked contrast to the lack 
of response of human umbilical veto endothelial cells to this 
drug. Based on the known functional differences of capillary 
and large vessel endothelial cells, biochemical differences be- 
tween these two cell types are not surprising. There are prob- 
ably many other biochemical differences which remain to be 
described. 
We have proposed that the stimulation of angiogenesis by 
specific molecules requires the secretion of latent collagenase 
and  PA (20).  With respect to this model, two aspects of the 
results described in the present paper should be emphasized. 
First, BCE cells are capable of synthesizing increased amounts 
of both latent collagenase and PA when exposed to TPA. This 
is in contrast to two other types of endothelial cells, BAE ceils 
and  human  umbilical  vein  endothelia  cells,  which  do  not 
exhibit the coordinated increase in production of both enzymes 
in response to TPA.  Human  umbilical vein endothelial cells 
increase only the production of latent collagenase when  ex- 
posed to TPA (19), while BAE cells increase only PA synthesis 
when exposed to TPA (14). 
Second,  the ability of BCE  cells to respond to angiogenic 
stimuli can  potentially be  used  to  identify and  purify angi- 
ogenic stimulators. In this regard, it should be stated that TPA 
has not been described to be an angiogenic agent. However, 
given  the  strong  inflammatory nature  of this  compound,  it 
would not be surprising if it were angiogenic. Since the sarcoma 
180 cells used to condition the growth medium used for BCE 
ceils do produce an angiogenic factor (25),  we were somewhat 
surprised at  the  rather  low  levels of proteases produced  by 
control BCE cells. This may be due in part to a reversal of the 
stimulation during the  1-d conditioning period before assays 
were initiated as well as the fact that the angiogenic factor may 
be produced in less than optimal amounts under the conditions 
used to normally culture the sarcoma 180 cells. Experiments to 
test the effects of bona fide angiogenic stimulators on protease 
production by BCE cells as well as other aspects of this model 
are currently underway. 
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